Millennium Management
WHWK

Millennium Management’s Whitehawk Therapeutics WHWK Stock Holding History

Millennium Management’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.07M Buy
+309,674
New +$969K ﹤0.01% 4345
2025
Q2 		– Sell
-44,823
Closed -$79.8K – 6472
2025
Q1 		$79.8K Sell
44,823
-129,175
-74% -$337K ﹤0.01% 5469
2024
Q4 		$549K Sell
173,998
-2,785
-2% -$6.31K ﹤0.01% 4675
2024
Q3 		$364K Sell
176,783
-49,302
-22% -$79.7K ﹤0.01% 5072
2024
Q2 		$330K Buy
+226,085
New +$419K ﹤0.01% 4854
2023
Q2 		– Sell
-72,375
Closed -$524K – 6802
2023
Q1 		$524K Sell
72,375
-2,214
-3% -$23.7K ﹤0.01% 4578
2022
Q4 		$957K Sell
74,589
-83,027
-53% -$1.08M ﹤0.01% 4211
2022
Q3 		$2.23M Buy
157,616
+127,652
+426% +$1.68M ﹤0.01% 3645
2022
Q2 		$369K Sell
29,964
-170,936
-85% -$2.54M ﹤0.01% 5192
2022
Q1 		$3.41M Buy
+200,900
New +$3.85M ﹤0.01% 3367
2021
Q4 		– Sell
-28,343
Closed -$832K – 7482
2021
Q3 		$832K Buy
28,343
+23,409
+474% +$713K ﹤0.01% 4875
2021
Q2 		$125K Buy
+4,934
New +$113K ﹤0.01% 6177
2020
Q4 		– Sell
-3,972
Closed -$89 – 5660
2020
Q3 		$89 Buy
+3,972
New +$83.6K ﹤0.01% 4242
2018
Q3 		– Sell
-15,000
Closed -$934K – 4341
2018
Q2 		$934K Buy
+15,000
New +$907K ﹤0.01% 2881

Other funds holding WHWK

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $134M AUM
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

Millennium Management's WHWK Position: Q1 2026 in Review

Millennium Management opened a new position in Whitehawk Therapeutics (WHWK) in Q1 2026: 309,674 shares worth $1.07M. The stake represents ﹤0.01% of the portfolio and ranks #4345 among its holdings. This is a return to the name: Millennium Management previously reported a position in WHWK as recently as Q1 2025.

Millennium Management first reported a position in WHWK in Q2 2018 and has held it in 14 quarters since. The position peaked at $3.41M in Q1 2022. 62 funds tracked by Wall St. Rank hold WHWK as of Q1 2026.

  • Millennium Management held 309,674 shares of Whitehawk Therapeutics worth $1.07M as of Q1 2026.
  • Whitehawk Therapeutics was a new Millennium Management position in Q1 2026.
  • Whitehawk Therapeutics made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #4345 holding.
  • Millennium Management first reported a position in Whitehawk Therapeutics in Q2 2018 and has held it in 14 quarters since.
  • Millennium Management's Whitehawk Therapeutics position peaked at $3.41M in Q1 2022.
  • 62 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.